Skip to main content

Table 3 Postoperative variables

From: Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study

 

Terlipressin group (n = 50)

Placebo group (n = 50)

P value

NE

Pt (n)

2

15

< 0.001*

Dose (μg.kg−1.min−1)

0 ± 0.009

0.03 ± 0.042

< 0.001*

E

Pt (n)

19

21

0.683

Dose (μg.kg−1.min−1)

0.04 ± 0.05

0.05 ± 0.051

0.723

Inotropic score

3 (0–9)

7 (3–11)

0.014*

Vasopressor dependency index

0.06 ± 0.065

0.1 ± 0.074

0.012*

  1. n number of patients, NE norepinephrine, E epinephrine
  2. Mean ± SD
  3. P value is significant when P < 0.05